Recent Articles from Associated Press
Berkshire Hathaway to pay $9.7 billion for OxyChem, potentially Buffett’s last big deal
Berkshire Hathaway will acquire Occidental’s chemical unit for $9.7B, a major deal as Warren Buffett signals succession to Greg Abel.
Tesla reports surprise increase in car sales in the third quarter
Tesla Q3 sales rose 7% to 497,099 vehicles, rebounding after declines as buyers rushed to use the expiring $7,500 EV credit.
Fired Surface Transportation Board member sues Trump over his dismissal ahead of rail merger review
Robert Primus sues Trump, claiming his firing from the Surface Transportation Board threatens the board’s independence.
US stocks hit new highs despite government shutdown
AOL has officially shut down its dial-up internet service, marking the end of an era that first connected millions to the web.
AOL officially ends dial up internet service after decades
AOL has officially shut down its dial-up internet service, marking the end of an era that first connected millions to the web.
Shutdown halts key economic data as Fed weighs rate cuts
The government shutdown delays jobs and inflation reports, leaving the Fed with less data as it considers more rate cuts.
Senate deadlock extends Trump-era government shutdown
U.S. shutdown begins after Senate gridlock on health care, furloughing 750,000 workers and raising fears of nationwide economic fallout.
Wall Street yawns at DC’s looming shutdown as US stocks head toward another winning month
U.S. stocks inched higher Tuesday, with the S&P 500 on track for a fifth straight winning month despite looming government shutdown risks.
Spotify CEO Daniel Ek steps down, Co-CEOs named
LONDON (AP) — Spotify said Tuesday that founder Daniel Ek is stepping down as CEO to become the executive chairman, in an announcement that sent its shares sliding in Tuesday trading. The Stockholm-based streaming giant said Ek will be replaced by two lieutenants who will become co-CEOs: Chief Product and Technology Officer Gustav Söderström and […]
Pfizer agrees to lower drug costs, $70B US investment
Pfizer will lower drug costs for Medicaid and invest $70B in U.S. manufacturing under a deal announced with President Trump.



















